Clinical efficacy of decitabine in combination with standard-dose cytarabine, aclarubicin hydrochloride, and granulocyte colony-stimulating factor in the treatment of young patients with newly diagnosed acute myeloid leukemia

Purpose: The chemotherapeutic regimen DCAG (decitabine with cytarabine, aclarubicin hydrochloride, and granulocyte colony-stimulating factor) is effective for elderly patients with acute myeloid leukemia, but recommendations for young patients remain controversial. This study investigated the tolera...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Onco Targets Ther
Main Authors: Dou, Liping, Xu, Qingyu, Wang, Mengzhen, Xiao, Yang, Cheng, Longcan, Li, Honghua, Huang, Wenrong, Mei, Junhui, Jing, Yu, Bo, Jian, Liu, Daihong, Yu, Li
Formato: Artigo
Idioma:Inglês
Publicado em: Dove 2019
Assuntos:
Original Research
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC6605041/
https://ncbi.nlm.nih.gov/pubmed/31303761
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2147/OTT.S200005
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados